Skip to content

Birchview Capital, LP

Follow

13F filer, CIK 1618205, BURLINGTON, VT

Birchview Capital, LP reported $173,107,278 across 79 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 56.04% of the portfolio.

Accepted , ingested 13F-HR 0001618205-26-000005

Period
2026-09-30
Reported value
$173M
Holdings
79
Top 10 weight
56.04%
New
23
Sold out
16

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RAREnew+373,671$5.62M
CONTINEUM THERAPEUTICS INCnew+3,500$2.27M
IRLAnew+40,601$1.26M
VALNnew+201,390$1.25M
DFTXadded+32,000$1.22M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BMYreduced-72,998-$4.56M
PACBreduced-1,190,000-$2.82M
VERAexited-57,758-$2.48M
QUREexited-50,697-$2.34M
KLACreduced-11,533-$2.25M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001618205-26-000005, largest first. % of portfolio is the value over $173,107,278, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KLACKLA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,848 shares; 2025Q3: 21,883 shares; 2025Q4: 21,883 shares; 2026Q1: 19,883 shares; 2026Q2: 178,471 shares; 2026Q3: 166,938 shares 166,938$32.5M18.8%-11,533Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 685,182 shares; 2025Q1: 685,192 shares; 2025Q2: 323,358 shares; 2025Q3: 316,842 shares; 2025Q4: 302,842 shares; 2026Q1: 306,268 shares; 2026Q2: 297,243 shares; 2026Q3: 224,245 shares 224,245$14M8.08%-72,998Timeline
LRCXLAM RESEARCH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,329 shares; 2026Q1: 36,000 shares; 2026Q2: 35,000 shares; 2026Q3: 30,000 shares 30,000$9.86M5.69%-5,000Timeline
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,736,113 shares; 2025Q1: 5,736,113 shares; 2025Q2: 5,736,113 shares; 2025Q3: 286,804 shares; 2025Q4: 286,804 shares; 2026Q1: 286,804 shares; 2026Q2: 286,804 shares; 2026Q3: 286,804 shares 286,804$8.56M4.94%0
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 74,000 shares; 2025Q1: 66,000 shares; 2025Q2: 67,200 shares; 2025Q3: 67,200 shares; 2025Q4: 67,200 shares; 2026Q1: 47,200 shares; 2026Q2: 57,200 shares; 2026Q3: 55,200 shares 55,200$6.36M3.67%-2,000Timeline
OVVOVINTIV INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 52,200 shares; 2025Q1: 52,200 shares; 2025Q2: 107,500 shares; 2025Q3: 107,500 shares; 2025Q4: 107,500 shares; 2026Q1: 107,500 shares; 2026Q2: 107,500 shares; 2026Q3: 107,500 shares 107,500$6.22M3.59%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,000 shares; 2025Q1: 16,000 shares; 2025Q2: 18,000 shares; 2025Q3: 22,000 shares; 2025Q4: 62,000 shares; 2026Q1: 62,000 shares; 2026Q2: not reported; 2026Q3: 373,671 shares 373,671$5.62M3.24%newTimeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 128,768 shares; 2025Q2: 178,768 shares; 2025Q3: 296,955 shares; 2025Q4: 705,955 shares; 2026Q1: 625,980 shares; 2026Q2: 666,196 shares; 2026Q3: 715,955 shares 715,955$5.18M2.99%+49,759Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 48,000 shares; 2025Q1: 48,002 shares; 2025Q2: 48,000 shares; 2025Q3: 48,000 shares; 2025Q4: 55,000 shares; 2026Q1: 35,000 shares; 2026Q2: 35,018 shares; 2026Q3: 35,000 shares 35,000$4.93M2.85%-18Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 304,574 shares; 2025Q1: 332,974 shares; 2025Q2: 451,019 shares; 2025Q3: 549,019 shares; 2025Q4: 441,019 shares; 2026Q1: 449,019 shares; 2026Q2: 449,019 shares; 2026Q3: 449,019 shares 449,019$3.76M2.17%0Timeline
HALOHALOZYME THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,100 shares; 2025Q4: 10,100 shares; 2026Q1: 10,100 shares; 2026Q2: 33,251 shares; 2026Q3: 33,351 shares 33,351$3.68M2.13%+100Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 210,000 shares; 2025Q1: 210,005 shares; 2025Q2: 210,000 shares; 2025Q3: 210,000 shares; 2025Q4: 260,000 shares; 2026Q1: 210,000 shares; 2026Q2: 178,110 shares; 2026Q3: 138,000 shares 138,000$3.59M2.07%-40,110Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,240 shares; 2025Q1: 30,240 shares; 2025Q2: 30,940 shares; 2025Q3: 28,690 shares; 2025Q4: 27,190 shares; 2026Q1: 27,190 shares; 2026Q2: 27,190 shares; 2026Q3: 25,190 shares 25,190$3.57M2.06%-2,000Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 338,400 shares; 2025Q1: 263,400 shares; 2025Q2: 187,800 shares; 2025Q3: 171,000 shares; 2025Q4: 171,000 shares; 2026Q1: 171,000 shares; 2026Q2: 171,000 shares; 2026Q3: 171,000 shares 171,000$3.45M1.99%0Timeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,000 shares; 2025Q3: 60,000 shares; 2025Q4: 315,400 shares; 2026Q1: 445,400 shares; 2026Q2: 385,900 shares; 2026Q3: 281,365 shares 281,365$3.39M1.96%-104,535Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,021 shares; 2025Q4: 31,000 shares; 2026Q1: 31,000 shares; 2026Q2: 81,000 shares; 2026Q3: 46,000 shares 46,000$2.79M1.61%-35,000Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 220,000 shares; 2026Q3: 226,992 shares 226,992$2.54M1.47%+6,992Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,500 shares; 2025Q1: 16,500 shares; 2025Q2: 16,500 shares; 2025Q3: 16,500 shares; 2025Q4: not reported; 2026Q1: 70,000 shares; 2026Q2: 93,601 shares; 2026Q3: 93,380 shares 93,380$2.52M1.45%-221Timeline
CONTINEUM THERAPEUTICS INCCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,500 shares 3,500$2.27M1.31%new
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,000 shares; 2026Q3: 21,000 shares 21,000$2.08M1.2%+4,000Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares; 2026Q2: 9,000 shares; 2026Q3: 9,000 shares 9,000$2.03M1.17%0Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 50,000 shares; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000$2.03M1.17%0Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares; 2026Q3: 52,000 shares 52,000$1.98M1.14%+32,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 30,000 shares; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares; 2026Q3: 30,000 shares 30,000$1.98M1.14%0Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,095 shares; 2026Q2: 69,900 shares; 2026Q3: 57,200 shares 57,200$1.85M1.07%-12,700Timeline
EQTEQT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 34,619 shares; 2025Q1: 34,619 shares; 2025Q2: 34,619 shares; 2025Q3: 34,619 shares; 2025Q4: 34,619 shares; 2026Q1: 34,619 shares; 2026Q2: 34,619 shares; 2026Q3: 34,619 shares 34,619$1.68M0.97%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 24,000 shares; 2025Q2: not reported; 2025Q3: 872,938 shares; 2025Q4: 1,592,938 shares; 2026Q1: 1,465,867 shares; 2026Q2: 1,675,000 shares; 2026Q3: 1,575,000 shares 1,575,000$1.64M0.95%-100,000Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 21,000 shares; 2025Q2: 21,000 shares; 2025Q3: 21,000 shares; 2025Q4: 21,000 shares; 2026Q1: 21,000 shares; 2026Q2: 21,032 shares; 2026Q3: 42,995 shares 42,995$1.6M0.92%+21,963Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 409,387 shares; 2026Q2: 408,100 shares; 2026Q3: 408,100 shares 408,100$1.54M0.89%0Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 148,000 shares; 2025Q1: 138,000 shares; 2025Q2: 103,000 shares; 2025Q3: 43,060 shares; 2025Q4: 43,000 shares; 2026Q1: 29,200 shares; 2026Q2: 29,000 shares; 2026Q3: 25,000 shares 25,000$1.47M0.85%-4,000Timeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 240,000 shares; 2026Q3: 430,000 shares 430,000$1.38M0.79%+190,000Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 7,500 shares; 2025Q2: 4,250 shares; 2025Q3: 3,000 shares; 2025Q4: 3,000 shares; 2026Q1: 4,500 shares; 2026Q2: 4,506 shares; 2026Q3: 2,500 shares 2,500$1.35M0.78%-2,006Timeline
FCXFREEPORT MCMORAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 18,033 shares; 2025Q3: 18,044 shares; 2025Q4: 18,046 shares; 2026Q1: 18,040 shares; 2026Q2: 18,035 shares; 2026Q3: 18,027 shares 18,027$1.26M0.73%-8Timeline
IRLAQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,601 shares 40,601$1.26M0.73%newTimeline
VALNVALNEVA SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 201,390 shares 201,390$1.25M0.72%newTimeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,000 shares; 2025Q3: 8,688 shares; 2025Q4: 8,688 shares; 2026Q1: 8,688 shares; 2026Q2: 8,741 shares; 2026Q3: 18,741 shares 18,741$1.23M0.71%+10,000Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,000 shares; 2025Q3: 105,000 shares; 2025Q4: 130,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 55,600 shares 55,600$1.2M0.69%+5,600Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,000 shares; 2025Q1: 6,000 shares; 2025Q2: 6,000 shares; 2025Q3: 6,000 shares; 2025Q4: 6,061 shares; 2026Q1: 6,000 shares; 2026Q2: 6,000 shares; 2026Q3: 6,000 shares 6,000$1.11M0.64%0Timeline
ANNEXON INCANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,370 shares 4,370$1.05M0.61%new
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,455 shares 90,455$1.02M0.59%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 310,930 shares; 2025Q1: 310,930 shares; 2025Q2: 310,930 shares; 2025Q3: 281,730 shares; 2025Q4: 281,730 shares; 2026Q1: 281,730 shares; 2026Q2: 281,937 shares; 2026Q3: 282,307 shares 282,307$1.01M0.58%+370Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,847 shares; 2025Q4: 29,847 shares; 2026Q1: 29,847 shares; 2026Q2: 29,847 shares; 2026Q3: 29,847 shares 29,847$947K0.55%0Timeline
QUIDELORTHO CORPQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 67,619 shares; 2025Q1: 67,619 shares; 2025Q2: 72,548 shares; 2025Q3: 72,548 shares; 2025Q4: 72,548 shares; 2026Q1: 82,548 shares; 2026Q2: 89,377 shares; 2026Q3: 89,377 shares 89,377$942K0.54%0
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$932K0.54%newTimeline
DISC MEDICINE INCDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450 shares 450$842K0.49%new
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 78,000 shares; 2025Q1: 88,404 shares; 2025Q2: 110,600 shares; 2025Q3: 110,600 shares; 2025Q4: 80,600 shares; 2026Q1: 12,900 shares; 2026Q2: 12,984 shares; 2026Q3: 22,935 shares 22,935$815K0.47%+9,951Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,400 shares 15,400$767K0.44%newTimeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 72,910 shares; 2025Q1: 72,910 shares; 2025Q2: 60,000 shares; 2025Q3: 40,000 shares; 2025Q4: 34,000 shares; 2026Q1: 24,000 shares; 2026Q2: 24,000 shares; 2026Q3: 24,000 shares 24,000$739K0.43%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 154,000 shares; 2025Q4: 462,700 shares; 2026Q1: 463,599 shares; 2026Q2: 313,616 shares; 2026Q3: 176,432 shares 176,432$649K0.38%-137,184Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 134,918 shares; 2025Q4: 74,918 shares; 2026Q1: 74,918 shares; 2026Q2: 75,147 shares; 2026Q3: 224,918 shares 224,918$603K0.35%+149,771Timeline
SLGLSOL-GEL TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,600 shares 7,600$565K0.33%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 134,000 shares; 2025Q3: 174,000 shares; 2025Q4: 269,000 shares; 2026Q1: 219,000 shares; 2026Q2: 199,000 shares; 2026Q3: 59,000 shares 59,000$510K0.29%-140,000Timeline
CRMDCORMEDIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,874 shares 65,874$507K0.29%newTimeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 120,000 shares; 2026Q3: 120,000 shares 120,000$485K0.28%0Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,700 shares 90,700$476K0.28%newTimeline
ALTALTIMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 152,681 shares; 2026Q3: 160,964 shares 160,964$460K0.27%+8,283Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 24,000 shares 24,000$458K0.26%newTimeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,000 shares; 2025Q1: 8,000 shares; 2025Q2: 8,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,220 shares 36,220$424K0.24%newTimeline
AEMDAETHLON MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 62,837 shares 62,837$410K0.24%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 51,000 shares; 2025Q1: 51,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,573 shares; 2026Q1: 250,221 shares; 2026Q2: 200,543 shares; 2026Q3: 200,000 shares 200,000$382K0.22%-543Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 400,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,350,000 shares; 2026Q3: 160,000 shares 160,000$379K0.22%-1,190,000Timeline
TRINTRINITY CAP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000$351K0.2%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 71,218 shares; 2026Q3: 30,000 shares 30,000$328K0.19%-41,218Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 20,000 shares; 2025Q1: 20,000 shares; 2025Q2: 20,000 shares; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000$307K0.18%0Timeline
KBDCKAYNE ANDERSON BDC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000$251K0.15%0Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 60,296 shares 60,296$250K0.14%newTimeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,849 shares 36,849$234K0.14%newTimeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 21,917 shares 21,917$204K0.12%newTimeline
CRDLCARDIOL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$166K0.1%newTimeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 320,000 shares; 2026Q2: 20,655 shares; 2026Q3: 20,450 shares 20,450$157K0.09%-205Timeline
KAZIA THERAPEUTICS LTDKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 16,000 shares 16,000$154K0.09%new
KYNBKYNTRA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 22,566 shares; 2026Q2: 22,566 shares; 2026Q3: 22,566 shares 22,566$150K0.09%0Timeline
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,225,489 shares; 2025Q1: 1,187,735 shares; 2025Q2: 1,159,059 shares; 2025Q3: 711,175 shares; 2025Q4: 263,018 shares; 2026Q1: 165,094 shares; 2026Q2: 165,094 shares; 2026Q3: 165,094 shares 165,094$130K0.08%0Timeline
BMEABIOMEA FUSION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 93,500 shares 93,500$124K0.07%newTimeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 165,478 shares 165,478$90.1K0.05%newTimeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 342,275 shares; 2026Q3: 75,975 shares 75,975$66.1K0.04%-266,300Timeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 111,786 shares; 2026Q2: 16,712 shares; 2026Q3: 16,712 shares 16,712$36.8K0.02%0Timeline
DCGODOCGO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 764,062 shares; 2025Q1: 864,062 shares; 2025Q2: 764,062 shares; 2025Q3: 764,062 shares; 2025Q4: 49,908 shares; 2026Q1: 39,573 shares; 2026Q2: 39,062 shares; 2026Q3: 39,062 shares 39,062$15.6K0.01%0Timeline
CELG-RBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 98,527 shares 98,527$12.3K0.01%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VERAVERA THERAPEUTICS INC57,758$2.48Mshares
QUREUNIQURE NV50,697$2.34Mshares
BIOABIOAGE LABS INC69,000$1.69Mshares
GPCRSTRUCTURE THERAPEUTICS INC24,000$1.29Mshares
NVONOVO-NORDISK A S24,000$1.15Mshares
FDMT4D MOLECULAR THERAPEUTICS IN48,505$645Kshares
URGNUROGEN PHARMA LTD16,487$607Kshares
PHATPHATHOM PHARMACEUTICALS INC55,000$597Kshares
SVRASAVARA INC80,000$493Kshares
CADLCANDEL THERAPEUTICS INC47,756$492Kshares
CMPSCOMPASS PATHWAYS PLC30,000$424Kshares
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC42,952$420Kshares
CAPRCAPRICOR THERAPEUTICS INC14,352$346Kshares
GRCEGRACE THERAPEUTICS INC120,000$272Kshares
QNRXQUOIN PHARMACEUTICALS LTD20,000$96.8Kshares
GOSSGOSSAMER BIO INC18,176$2.99Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001618205-26-000005 base2026-11-13